Gritstone Bio shares are trading lower after B. Riley Securities downgraded the stock from Buy to Neutral and cut its price target from $3 to $1. Also, Jones Trading downgraded the stock from Buy to Hold.
Author: Benzinga Newsdesk | October 02, 2024 09:41am